# The TransCatheter Valve and Vessels Trial

> **NCT03424941** · NA · COMPLETED · sponsor: **Maatschap Cardiologie Zwolle** · enrollment: 172 (actual)

## Conditions studied

- Aortic Stenosis
- Multi Vessel Coronary Artery Disease
- TAVI
- CABG
- PCI
- Fractional Flow Reserve

## Interventions

- **DEVICE:** FFR-guided PCI and TAVI
- **DEVICE:** CABG and SAVR

## Key facts

- **NCT ID:** NCT03424941
- **Lead sponsor:** Maatschap Cardiologie Zwolle
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-31
- **Primary completion:** 2024-06-26
- **Final completion:** 2024-06-26
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2025-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03424941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03424941, "The TransCatheter Valve and Vessels Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03424941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*